These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34190779)

  • 1. IMPROVED ADHERENCE TO THE ESPGHAN GUIDELINES IS NECESSARY FOR DIAGNOSING CELIAC DISEASE IN CHILDREN: A SINGLE-CENTER EXPERIENCE.
    Lau WS; Heaton PA; Paul SP
    Arq Gastroenterol; 2021; 58(2):164-167. PubMed ID: 34190779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation and implementation of the revised European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines on pediatric celiac disease amongst consultant general pediatricians in Southwest of England.
    Paul SP; Adams HL; Basude D;
    Indian J Gastroenterol; 2019 Jun; 38(3):203-210. PubMed ID: 31183842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiac Disease Management in the United Kingdom Specialist Pediatric Gastroenterology Centers-A Service Survey.
    Paul SP; Balakumar V; Gillett PM
    J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):e149-e153. PubMed ID: 33908736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020.
    Husby S; Koletzko S; Korponay-Szabó I; Kurppa K; Mearin ML; Ribes-Koninckx C; Shamir R; Troncone R; Auricchio R; Castillejo G; Christensen R; Dolinsek J; Gillett P; Hróbjartsson A; Koltai T; Maki M; Nielsen SM; Popp A; Størdal K; Werkstetter K; Wessels M
    J Pediatr Gastroenterol Nutr; 2020 Jan; 70(1):141-156. PubMed ID: 31568151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence supporting safe diagnosis of coeliac disease in children with antitissue transglutaminase titre ≥5 times upper limit of normal.
    Paul SP; Raja DI; Sandhu BK; Rao SR; Spray CH; Wiskin AE; Selvarajan L; Volonaki E; Ramani P; Tashtoush LB; Basude D
    Arch Dis Child; 2022 Aug; 107(8):747-751. PubMed ID: 35172964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in pediatric celiac disease is independent of the diagnostic approach in patients with high antibody levels.
    Klöti S; Schaad J; Spalinger J; Schibli S; Hart L; Sokollik C; Righini-Grunder F
    J Pediatr Gastroenterol Nutr; 2024 Jul; 79(1):84-91. PubMed ID: 38769762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of the New ESPGHAN Guidelines for Diagnosing Coeliac Disease in Children from Resource Limited Countries.
    Paul SP; Mazhar H; Spray CH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):455-7. PubMed ID: 26101002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serological tests in the diagnosis of coeliac disease in children in New Zealand.
    Ho SS; Keenan JI; Day AS
    J Paediatr Child Health; 2020 Dec; 56(12):1906-1911. PubMed ID: 32946186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.
    Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD
    Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coeliac disease diagnosis: ESPGHAN 1990 criteria or need for a change? Results of a questionnaire.
    Ribes-Koninckx C; Mearin ML; Korponay-Szabó IR; Shamir R; Husby S; Ventura A; Branski D; Catassi C; Koletzko S; Mäki M; Troncone R; Zimmer KP;
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):15-9. PubMed ID: 21716133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19.
    Trovato CM; Montuori M; Cucchiara S; Oliva S
    Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1523-1526. PubMed ID: 32956181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prudence is necessary in the application of the new ESPGHAN criteria for celiac disease omitting duodenal biopsy: a case report.
    Schirru E; Jores RD; Congia M
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):679-80. PubMed ID: 24694761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines in an Australian paediatric population.
    Thompson G; Grover Z; Loh R; Mews C; Ravikumara M; Jevon G; D'Orsogna L; McLean-Tooke A
    Pathology; 2020 Aug; 52(5):568-575. PubMed ID: 32586687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESPGHAN 2012 Guidelines for Coeliac Disease Diagnosis: Validation Through a Retrospective Spanish Multicentric Study.
    Donat E; Ramos JM; Sánchez-Valverde F; Moreno A; Martinez MJ; Leis R; Peña-Quintana L; Castillejo G; Fernández S; Garcia Z; Ortigosa L; Balmaseda E; Marugán JM; Eizaguirre FJ; Lorenzo H; Barrio J; Ribes-Koninckx C;
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):284-91. PubMed ID: 26020370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence Supporting Serology-based Pathway for Diagnosing Celiac Disease in Asymptomatic Children From High-risk Groups.
    Paul SP; Sandhu BK; Spray CH; Basude D; Ramani P
    J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):641-644. PubMed ID: 28957985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years.
    Di Biase AR; Marasco G; Ravaioli F; Colecchia L; Dajti E; Lecis M; Passini E; Alemanni LV; Festi D; Iughetti L; Colecchia A
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?
    Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F
    Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study.
    Benelli E; Carrato V; Martelossi S; Ronfani L; Not T; Ventura A
    Arch Dis Child; 2016 Feb; 101(2):172-6. PubMed ID: 26578746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening.
    Webb C; Norström F; Myléus A; Ivarsson A; Halvarsson B; Högberg L; Lagerqvist C; Rosén A; Sandström O; Stenhammar L; Carlsson A
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):787-91. PubMed ID: 25564816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.